(Q38036687)

27 August 2017

title

HIV epidemic in Asia: optimizing and expanding vaccine development (English)

1 reference

27 August 2017

4

Jean-Louis Excler

1 reference

27 August 2017

Sorachai Nitayaphan

1

1 reference

27 August 2017

Viseth Ngauy

series ordinal

2

1 reference

27 August 2017

Robert O'Connell

series ordinal

3

1 reference

27 August 2017

publication date

1 July 2012

1 reference

Expert Review of Vaccines

27 August 2017

published in

1 reference

27 August 2017

volume

11

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

805-819

1 reference

Scale-up of national antiretroviral therapy programs: progress and challenges in the Asia Pacific region

27 August 2017

cites work

1 reference

Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update

21 January 2018

1 reference

Epidemiology of male same-sex behaviour and associated sexual health indicators in low- and middle-income countries: 2003-2007 estimates.

21 January 2018

1 reference

Sexual risk taking, STI and HIV prevalence among men who have sex with men in six Indonesian cities

21 January 2018

1 reference

Risk behaviour and HIV prevalence among men who have sex with men in a multiethnic society: a venue-based study in Kuala Lumpur, Malaysia.

21 January 2018

1 reference

HIV prevalence and risk behaviour among men who have sex with men in Vientiane Capital, Lao People's Democratic Republic, 2007.

21 January 2018

1 reference

Men who have sex with men in India: a systematic review of the literature

21 January 2018

1 reference

Sexual practices, HIV and sexually transmitted infections among self-identified men who have sex with men in four high HIV prevalence states of India

21 January 2018

1 reference

The epidemiology of human immunodeficiency virus infection, sexually transmitted infections, and associated risk behaviors among men who have sex with men in the Mekong Subregion and China: implications for policy and programming

21 January 2018

1 reference

Prevalence of unprotected anal intercourse and unprotected vaginal intercourse among HIV-positive men who have sex with men in China: a meta-analysis

21 January 2018

1 reference

Human immunodeficiency virus prevalence is increasing among men who have sex with men in China: findings from a review and meta-analysis

21 January 2018

1 reference

Prevalence of bisexual behaviour among bridge population of men who have sex with men in China: a meta-analysis of observational studies

21 January 2018

1 reference

HIV prevalence, risk behavior, hormone use and surgical history among transgender persons in Thailand

21 January 2018

1 reference

Sexual risk behaviour of men who have sex with men: emerging patterns and new challenges

21 January 2018

1 reference

Sexual risk behaviour for transmission of HIV in men who have sex with men: recent findings and potential interventions

21 January 2018

1 reference

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

21 January 2018

1 reference

Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings

21 January 2018

1 reference

Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre- and post-exposure prophylaxis against HIV infection.

21 January 2018

1 reference

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

21 January 2018

1 reference

Female sexual partners of injection drug users in Vietnam: an at-risk population in urgent need of HIV prevention services

21 January 2018

1 reference

Review of HIV and other sexually transmitted infections among female sex workers in China

21 January 2018

1 reference

Epidemiology of HIV and sexually transmitted infections in Thailand

21 January 2018

1 reference

Epidemiology of HIV and sexually transmitted infections in China

21 January 2018

1 reference

Impact of an intensive HIV prevention programme for female sex workers on HIV prevalence among antenatal clinic attenders in Karnataka state, south India: an ecological analysis

21 January 2018

1 reference

Global trends in molecular epidemiology of HIV-1 during 2000-2007.

21 January 2018

1 reference

Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: the relevance of genetic diversity and phylodynamics for vaccine strategies

21 January 2018

1 reference

AIDS and public policy: the lessons and challenges of "success" in Thailand

21 January 2018

1 reference

Trends in HIV Prevalence, Estimated HIV Incidence, and Risk Behavior Among Men Who Have Sex With Men in Bangkok, Thailand, 2003–2007.

21 January 2018

1 reference

HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand.

21 January 2018

1 reference

The expanding epidemics of HIV type 1 among men who have sex with men in low- and middle-income countries: diversity and consistency

21 January 2018

1 reference

A review of the epidemiology of HIV infection and prevention responses among MSM in Asia.

21 January 2018

1 reference

HIV incidence, risk factors, and motivation for biomedical intervention among gay, bisexual men, and transgender persons in Northern Thailand

21 January 2018

1 reference

HIV-vaccine research and development in Thailand: evolution and challenges

21 January 2018

1 reference

HIV vaccine research in Thailand: lessons learned

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

21 January 2018

1 reference

Safety profile of recombinant canarypox HIV vaccines

21 January 2018

1 reference

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.

21 January 2018

1 reference

Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1.

21 January 2018

1 reference

Acceptability of A-CASI by HIV-positive IDUs in a multisite, randomized, controlled trial of behavioral intervention (INSPIRE).

21 January 2018

1 reference

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand

21 January 2018

1 reference

Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148).

21 January 2018

1 reference

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

21 January 2018

1 reference

Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials

21 January 2018

1 reference

Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.

21 January 2018

1 reference

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate

21 January 2018

1 reference

An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection

21 January 2018

1 reference

Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults

21 January 2018

1 reference

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys

21 January 2018

1 reference

P19-01. Pre-clinical immunogenicity of mosaic Asian AE/B HIV-1 DNA vaccine in mice.

21 January 2018

1 reference

Incidence and Predictors of Human Immunodeficiency Virus Type 1 Seroconversion in Patients Attending Sexually Transmitted Disease Clinics in India

21 January 2018

1 reference

Spread of HIV infection in married monogamous women in India.

21 January 2018

1 reference

Risk factors and clinical presentation of acute primary HIV infection in India

21 January 2018

1 reference

Bisexuality, sexual risk taking, and HIV prevalence among men who have sex with men accessing voluntary counseling and testing services in Mumbai, India

21 January 2018

1 reference

Sexually transmitted infections and risk behaviors among transgender persons (Hijras) of Pune, India

21 January 2018

1 reference

HIV in Indian MSM: reasons for a concentrated epidemic & strategies for prevention

21 January 2018

1 reference

Genomic diversity of human immunodeficiency virus type-1 in India

21 January 2018

1 reference

Genetic diversity of HIV type 1 subtype C env gene sequences from India

21 January 2018

1 reference

Genetic architecture of HIV-1 genes circulating in north India & their functional implications

21 January 2018

1 reference

Evidence of a novel B/C recombinant exhibiting unique breakpoints of near full-length HIV type 1 genome from Northeastern India

21 January 2018

1 reference

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine

21 January 2018

1 reference

A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers

21 January 2018

1 reference

Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine

21 January 2018

1 reference

Design of a non-glycosylated outer domain-derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodies

21 January 2018

1 reference

China AIDS policy implementation: reversing the HIV/AIDS epidemic by 2015.

21 January 2018

1 reference

Characterization of five nearly full-length genomes of early HIV type 1 strains in Ruili city: implications for the genesis of CRF07_BC and CRF08_BC circulating in China

21 January 2018

1 reference

Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia

21 January 2018

1 reference

Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07_BC strains circulating in the Xinjiang Province of China.

21 January 2018

1 reference

Near full-length genomic characterization of a novel HIV type 1 CRF07_ BC/CRF08_ BC recombinant strain from Yunnan, China

21 January 2018

1 reference

Genetic diversity of HIV type 1 isolated from newly diagnosed subjects (2006-2007) in Beijing, China

21 January 2018

1 reference

Dynamic analysis of genetic diversity of gag and env regions of HIV-1 CRF07_BC recombinant in intravenous drug users in Xinjiang Uvghur Autonomous Region, China

21 January 2018

1 reference

Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China

21 January 2018

1 reference

Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China

21 January 2018

1 reference

Scientific approaches to AIDS prevention and control in China

21 January 2018

1 reference

Molecularly cloned SHIV-CN97001: a replication-competent, R5 simian/human immunodeficiency virus containing env of a primary Chinese HIV-1 clade C isolate

21 January 2018

1 reference

Controlled release of PEI/DNA complexes from PLGA microspheres as a potent delivery system to enhance immune response to HIV vaccine DNA prime/MVA boost regime

21 January 2018

1 reference

Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine

21 January 2018

1 reference

Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes

21 January 2018

1 reference

A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies

21 January 2018

1 reference

Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.

21 January 2018

1 reference

Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.

21 January 2018

1 reference

Comparison of the expression and immunogenicity of wild-type and sequence-modified HIV-1 gag genes in a recombinant Sendai virus vector

21 January 2018

1 reference

Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine

21 January 2018

1 reference

Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: differences from the human counterparts and implications for HIV-1 vaccine development

21 January 2018

1 reference

Deglycosylation of HIV-1 AE Gp140 enhances the capacity to elicit neutralizing antibodies against the heterologous HIV-1 clade.

21 January 2018

1 reference

Short communication: enhancement of immunogenicity of replication-defective adenovirus-based human immunodeficiency virus vaccines in rhesus monkeys

21 January 2018

1 reference

HIV incidence, retention rate, and baseline predictors of HIV incidence and retention in a prospective cohort study of injection drug users in Xinjiang, China.

21 January 2018

1 reference

Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking route

21 January 2018

1 reference

Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.

21 January 2018

1 reference

An 11-Year Surveillance of HIV Type 1 Subtypes in Nagoya, Japan

21 January 2018

1 reference

Survey investigating homosexual behaviour among adult males used to estimate the prevalence of HIV and AIDS among men who have sex with men in Japan

21 January 2018

1 reference

The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity

21 January 2018

1 reference

Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors

21 January 2018

1 reference

Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells.

21 January 2018

1 reference

21 January 2018

1 reference

Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults

21 January 2018

1 reference

Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial

21 January 2018

1 reference

Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques

21 January 2018

1 reference

Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques

21 January 2018

1 reference

Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model

21 January 2018

1 reference

Induction of Gag-specific T-cell responses by therapeutic immunization with a Gag-expressing Sendai virus vector in macaques chronically infected with simian-human immunodeficiency virus

21 January 2018

1 reference

Immunogenic comparison of chimeric adenovirus 5/35 vector carrying optimized human immunodeficiency virus clade C genes and various promoters

21 January 2018

1 reference

Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys

21 January 2018

1 reference

Increasing diversity of Human Immunodeficiency Virus type 1 subtypes circulating in Australia

21 January 2018

1 reference

A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1.

21 January 2018

1 reference

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens.

21 January 2018

1 reference

Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood

21 January 2018

1 reference

Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques

21 January 2018

1 reference

Rapid degranulation of NK cells following activation by HIV-specific antibodies.

21 January 2018

1 reference

High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40).

21 January 2018

1 reference

Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1.

21 January 2018

1 reference

HIV vaccines: lessons learned and the way forward

21 January 2018

1 reference

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

21 January 2018

1 reference

Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus

21 January 2018

1 reference

Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection

21 January 2018

1 reference

Antiretroviral therapy in prevention of HIV and TB: update on current research efforts

21 January 2018

1 reference

AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines

21 January 2018

1 reference

Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia

21 January 2018

1 reference

Inconsistent Condom Use Among Young Men Who Have Sex With Men, Male Sex Workers, and Transgenders in Thailand

21 January 2018

1 reference

Accelerating HIV vaccine development

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.49

1 reference

27 August 2017

1 reference